PROmyBETAapp
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- Interferon beta-1b
Interferon alpha/beta receptor agonist
- Betaconnect auto-injector
- myBETAapp
What it measured
Main measures
Compliance to therapy (%)
6 months
Persistence of therapy (yes, no)
6 months
Adherence to therapy (yes, no)
6 months
Quality of life (reported by participants)
Other measures (2)
Proportion of patients consenting to participate in this study among those using the myBETAapp
3 months
Proportion of patients volunteering to record wellness related data in each of the following categories on the "Wellness chart" on the myBETAapp
3 months
VisionThinking and memoryWalking and mobilityPhysical functionBladder, bowel and sexual function
Who could take part
Relapsing and progressive · 18 and over
Inclusion Criteria: * Patients aged ≥ 18 years. * Patients on treatment with Betaferon (every Betaferon box contains a "Mixject" number, which is a product specific number unrelated to the study. Only patients prescribed Betaferon for their MS will be able to use the myBETAapp and participate in the study). * Patients must be using the myBETAapp. * Electronic informed consent must be obtained. Exclusion Criteria: -There are no exclusion criteria for participation in this study.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The planned study will be a prospective, non-interventional, observational cohort study using the structure of a registry. Medication usage behavior will be observed for 6 months, while documentation behavior on the wellness tracker in the myBETAapp will be observed for 3 months.
Papers
Loading reviews and guidelines…
Related trials
- DESIRE MS
Phase 3 · Recruiting
Still running
- Study to Evaluate Oral BIIB061 Added to Interferon-beta1 …
Phase 2 · Withdrawn
Stopped: not working
- Evaluating the Use of Prednisone to Decrease Pegylated In…
Phase 4 · Status unknown
Result in a paper, not read yet
- TOLERVIT-MS
Phase 1 · Status unknown
Result in a paper, not read yet
- SYNERGY
Phase 2 · Completed
Met its main goal
- China Betaferon Adherence, Coping and Nurse Support Study
Completed
No result found
History
Started
Sept 2017
Main results due
May 2018
Finished
May 2018
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error